Aggiornamento aziendale20 ott 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale14 ott 2026ENLakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell TherapeuticsLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale13 ott 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale8 ott 2026ENLakefront Receives Transparency Notification from Bank of AmericaLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale6 ott 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale29 set 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale22 set 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale15 set 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale8 set 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale8 set 2026ENLakefront to Present at the Morgan Stanley 24th Annual Global Healthcare ConferenceLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale1 set 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale25 ago 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale24 ago 2026ENU.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of PemphigusLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale24 ago 2026ENLakefront Receives Transparency Notification from Bank of AmericaLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale18 ago 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale12 ago 2026ENAcquisition of Own SharesLakefront Biotherapeutics NVCompany newsroom
Aggiornamento aziendale10 ago 2026ENLakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business UpdateLakefront Biotherapeutics NVCompany newsroom
